Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

NCT00454649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Axitinib + Paclitaxel + Carboplatin (Cohort 1)
DRUG: Axitinib + Paclitaxel + Carboplatin (Cohort 2)
DRUG: Axitinib + Paclitaxel + Carboplatin (Cohort 3)
DRUG: Axitinib + Paclitaxel (Cohort 4)
DRUG: Axitinib + Docetaxel + Carboplatin (Cohort 4a)
DRUG: Axitinib + Docetaxel (Cohort 5)
DRUG: Axitinib + Capecitabine (Cohort 6)
DRUG: Axitinib + Capecitabine (Cohort 7)
DRUG: Axitinib + Gemcitabine + Cisplatin (Cohort 8)
DRUG: Axitinib + Pemetrexed + Cisplatin (Cohort 9)

Sponsor

Pfizer